Abcellera Biologics Stock Forecast - Daily Balance Of Power
| ABCL Stock | USD 3.02 0.07 2.37% |
Abcellera Stock Forecast is based on your current time horizon. Although Abcellera Biologics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Abcellera Biologics' systematic risk associated with finding meaningful patterns of Abcellera Biologics fundamentals over time.
Abcellera |
Open Interest Against 2024-12-20 Abcellera Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Abcellera Biologics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Abcellera Biologics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Abcellera Biologics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Abcellera Biologics' open interest, investors have to compare it to Abcellera Biologics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Abcellera Biologics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Abcellera. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (0.81) | (0.42) |
| Check Abcellera Biologics Volatility | Backtest Abcellera Biologics | Trend Details |
Abcellera Biologics Trading Date Momentum
| On November 14 2024 Abcellera Biologics was traded for 2.76 at the closing time. The top price for the day was 2.97 and the lowest listed price was 2.76 . The trading volume for the day was 2.8 M. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.48% . The overall trading delta against the current closing price is 8.90% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Abcellera Biologics to competition |
Other Forecasting Options for Abcellera Biologics
For every potential investor in Abcellera, whether a beginner or expert, Abcellera Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Abcellera Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Abcellera. Basic forecasting techniques help filter out the noise by identifying Abcellera Biologics' price trends.Abcellera Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abcellera Biologics stock to make a market-neutral strategy. Peer analysis of Abcellera Biologics could also be used in its relative valuation, which is a method of valuing Abcellera Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Abcellera Biologics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Abcellera Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Abcellera Biologics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Abcellera Biologics Market Strength Events
Market strength indicators help investors to evaluate how Abcellera Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Abcellera Biologics shares will generate the highest return on investment. By undertsting and applying Abcellera Biologics stock market strength indicators, traders can identify Abcellera Biologics entry and exit signals to maximize returns.
| Accumulation Distribution | 120679.0 | |||
| Daily Balance Of Power | 0.4375 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 2.98 | |||
| Day Typical Price | 2.99 | |||
| Price Action Indicator | 0.075 | |||
| Period Momentum Indicator | 0.07 |
Abcellera Biologics Risk Indicators
The analysis of Abcellera Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Abcellera Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting abcellera stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.92 | |||
| Semi Deviation | 2.8 | |||
| Standard Deviation | 3.91 | |||
| Variance | 15.31 | |||
| Downside Variance | 9.93 | |||
| Semi Variance | 7.85 | |||
| Expected Short fall | (3.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Abcellera Biologics to cross-verify your projections. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.61) | Revenue Per Share 0.112 | Quarterly Revenue Growth (0.01) | Return On Assets (0.13) |
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.